The use of digital pathology and image analysis in clinical trials
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Digital pathology and image analysis potentially provide greater accuracy, reproducibility and standardisation of pathology‐based trial entry criteria and endpoints, alongside extracting new insights from both existing and novel features. Image analysis has great potential to identify, extract and quantify features in greater detail in comparison to pathologist assessment, which may produce improved prediction models or perform tasks beyond manual capability. In this article, we provide an overview of the utility of such technologies in clinical trials and provide a discussion of the potential applications, current challenges, limitations and remaining unanswered questions that require addressing prior to routine adoption in such studies. We reiterate the value of central review of pathology in clinical trials, and discuss inherent logistical, cost and performance advantages of using a digital approach. The current and emerging regulatory landscape is outlined. The role of digital platforms and remote learning to improve the training and performance of clinical trial pathologists is discussed. The impact of image analysis on quantitative tissue morphometrics in key areas such as standardisation of immunohistochemical stain interpretation, assessment of tumour cellularity prior to molecular analytical applications and the assessment of novel histological features is described. The standardisation of digital image production, establishment of criteria for digital pathology use in pre‐clinical and clinical studies, establishment of performance criteria for image analysis algorithms and liaison with regulatory bodies to facilitate incorporation of image analysis applications into clinical practice are key issues to be addressed to improve digital pathology incorporation into clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908 · cited 1×
“…for digital pathology applications [Visiopharm, De fi niens Tissue Studio, Indica Labs HALO (Cor-rales, New Mexico, USA)], or alternatively an open source software programme such as QuPath Open Source Software for Quantitative Pathology or Ima-geJ (Image Process and Analysis in Java) [16 – 18].”
Ehteshami Bejnordi, B., Veta, M., Johannes van Diest, P., van Ginneken, B., Karssemeijer, N., Litjens, G., van der Laak, J. A. W. M., and the CAMELYON16 Consortium, Hermsen, M., Manson, Q. F., et al. (2017) · JAMA · doi:10.1001/jama.2017.14585 · Cited by 3,293
The EU General Data Protection Regulation (GDPR)
Voigt, P., & von dem Bussche, A. (2017) · doi:10.1007/978-3-319-57959-7 · Cited by 3,001
Coudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A. L., Razavian, N., & Tsirigos, A. (2018) · Nature Medicine · doi:10.1038/s41591-018-0177-5 · Cited by 2,930 · cited 1×
“Deep learning-based artificial intelligence (AI) has identified novel markers of distant metastasis in colorectal cancer [9] and novel indications of morpho-molecular associations [10].”
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · cited 1×
“…is the underlying basis for the Immunoscore ™ (Laboratory of Integrative Cancer Immunology INSERM, Paris, France) technique in colorectal adenocarcinoma: patients with a low CD3+ and CD8+ T cell density in the tumour centre and invasive margin are at an increased risk for disease relapse [45,46].”
Sirinukunwattana, K., Raza, S. E. A., Tsang, Y.-W., Snead, D. R. J., Cree, I. A., & Rajpoot, N. M. (2016) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2016.2525803 · Cited by 1,224 · cited 1×
“The identi fi cation of cancer cells, stromal tissue or in fl ammatory cells [48] typically requires accurate ground-truth training datasets and large numbers of cases to provide optimal automated assessment.”
Self-citationPredicting cancer outcomes from histology and genomics using convolutional networks
Mobadersany, P., Yousefi, S., Amgad, M., Gutman, D. A., Barnholtz-Sloan, J. S., Velázquez Vega, J. E., Brat, D. J., & Cooper, L. A. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717139115 · Cited by 1,084 · cited 1×
“Correlating morphological patterns with genetic strati fi ers using traditional machine learning or deep learning demonstrates substantial promise [11,12].”
Saltz, J., Gupta, R., Hou, L., Kurc, T., Singh, P., Nguyen, V., Samaras, D., Shroyer, K. R., Zhao, T., Batiste, R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.086 · Cited by 1,027
Deep learning based tissue analysis predicts outcome in colorectal cancer
Bychkov, D., Linder, N., Turkki, R., Nordling, S., Kovanen, P. E., Verrill, C., Walliander, M., Lundin, M., Haglund, C., & Lundin, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-21758-3 · Cited by 644 · cited 2×
“Examples include the scoring of PD-L1 [3], quanti fi cation of immune in fi ltrates to predict outcomes in testicular tumours [4], detecting sentinel lymph node metastases [5] and superior prediction of colorectal cancer outcome compared to standard morphological assessment [6].”
Self-citation
Cited by
Data-efficient and weakly supervised computational pathology on whole-slide images
Lu, M. Y., Williamson, D. F. K., Chen, T. Y., Chen, R. J., Barbieri, M., & Mahmood, F. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00682-w · Cited by 2,282
Digital pathology and artificial intelligence in translational medicine and clinical practice
Baxi, V., Edwards, R., Montalto, M., & Saha, S. (2022) · Modern Pathology · doi:10.1038/s41379-021-00919-2 · Cited by 592
The Lancet Commission on diagnostics: transforming access to diagnostics
Fleming, K. A., Horton, S., Wilson, M. L., Atun, R., DeStigter, K., Flanigan, J., Sayed, S., Adam, P., Aguilar, B., Andronikou, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00673-5 · Cited by 471
Federated learning for computational pathology on gigapixel whole slide images
Lu, M. Y., Chen, R. J., Kong, D., Lipkova, J., Singh, R., Williamson, D. F. K., Chen, T. Y., & Mahmood, F. (2022) · Medical Image Analysis · doi:10.1016/j.media.2021.102298 · Cited by 267
Geaney, A., O’Reilly, P., Maxwell, P., James, J. A., McArt, D., & Salto-Tellez, M. (2023) · Oncogene · doi:10.1038/s41388-023-02857-6 · Cited by 42
Metadata
- Authors
- Pell, R., Oien, K., Robinson, M., Pitman, H., Rajpoot, N., Rittscher, J., Snead, D., Verrill, C., & on behalf of the UK National Cancer Research Institute (NCRI) Cellular‐Molecular Pathology (CM‐Path) quality assurance working group
- Venue
- The Journal of Pathology: Clinical Research
- Publisher
- Wiley
- Published
- 2019-03-25
- Volume
- 5
- Issue
- 2
- Pages
- 81-90
- ISSN
- 2056-4538 (ISSN-L)
- OpenAlex
- W2912814480
- Cited by
- 109
- References
- 10
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.